iVascular SLU has announced that it has received approval for selling its coronary and peripheral products in India.
The Indian medical devices market is the fourth largest in Asia and part of the global top 20.
“iVascular’s product portfolio was created with the latest technologies to improve patients’ outcomes and provide physicians with the solution for the challenges that they meet daily. We are now excited to expand our presence further into Asian market”, said Lluis Duocastella, iVascular’s CEO.
The approval will cover iVascular’s peripheral drug-coated balloons and drug-eluting stents, which are now available for sale on the Indian subcontinent.
